← Leaderboards
Alan Paul Kozikowski
Georgetown University
$7,525,629
Attributed
$7,525,629
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–07$2M$1.5M$1M$500K$0
'05
'06
'07
Funding mix
By agency
NIH$7,525,629 · 8
By mechanism
R01$7,525,629 · 8
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Chemical Synthesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$156,891,547
- David H Walker · University Of Texas Medical Br Galveston$61,066,312
- Jay D Keasling · University Of California-Berkeley$45,089,571
- Marc A Hillmyer · University Of Minnesota-Twin Cities$43,647,280
- Huw M Davies · Suny At Buffalo$42,517,196
- Harry B Gray · California Institute Of Technology$40,481,419
Research focus
Chemical SynthesisAnalogReceptor BindingSerotoninNeuropharmacologyCocaineDrug Design /Synthesis /ProductionChemical Structure FunctionChemical BindingDopamineLigandsLaboratory RatChemical ModelsLaboratory MouseTropanesGamma AminobutyrateNeurotransmitter TransportProtein Kinase CComputer SimulationBryostatinDrug Addiction AntagonistBehavior TestDrug ReceptorsAlzheimer&Apos
Grant awards (23)
Chemistry and Biology of 5-HT2C Receptor Ligands for Drug Abuse$507,813
R01 · FY2007 · DA · contact PI
Molecular Interventions for Bipolar Disorder$443,968
R01 · FY2007 · MH · contact PI
PKC Modulators for the Treatment of Alzheimer's disease$397,112
R01 · FY2007 · AG · contact PI
Chemistry and Pharmacology of a New Nicotine Ligands$288,775
R01 · FY2007 · DA · contact PI
PKC Modulators for the Treatment of Alzheimer's disease$398,580
R01 · FY2006 · AG · contact PI
Chemistry and Pharmacology of a New Nicotine Ligands$288,805
R01 · FY2006 · DA · contact PI
PKC Modulators for the Treatment of Alzheimer's disease$441,119
R01 · FY2005 · AG
Chemistry and Pharmacology of a New Nicotine Ligands$287,213
R01 · FY2005 · DA
CHEMICAL AND PHARMACOLOGICAL STUDIES OF COCAINE ANALOGS$369,212
R01 · FY2004 · DA
Chemistry and Pharmacology of a New Nicotine Ligands$278,916
R01 · FY2004 · DA
CHEMICAL AND PHARMACOLOGICAL STUDIES OF COCAINE ANALOGS$358,771
R01 · FY2003 · DA
Chemistry and Pharmacology of a New Nicotine Ligands$284,613
R01 · FY2003 · DA
CHEMICAL AND PHARMACOLOGICAL STUDIES OF COCAINE ANALOGS$347,402
R01 · FY2002 · DA
DESIGN OF LIGANDS SELECTIVE FOR THE DAG SUPERFAMILY$307,818
R01 · FY2002 · CA
DESIGN OF LIGANDS SELECTIVE FOR THE DAG SUPERFAMILY$1,957
R01 · FY2002 · CA
NEW LIGANDS FOR METABOTROPIC GLUTAMATE RECEPTORS$349,050
R01 · FY2001 · NS
CHEMICAL AND PHARMACOLOGICAL STUDIES OF COCAINE ANALOGS$336,362
R01 · FY2001 · DA
DESIGN OF LIGANDS SELECTIVE FOR THE DAG SUPERFAMILY$300,886
R01 · FY2001 · CA
BIOLOGICAL STUDIES OF PIPERIDINE ANALOGS OF COCAINE$286,314
R01 · FY2001 · DA
NEW LIGANDS FOR METABOTROPIC GLUTAMATE RECEPTORS$340,369
R01 · FY2000 · NS
CHEMICAL AND PHARMACOLOGICAL STUDIES OF COCAINE ANALOGS$339,962
R01 · FY2000 · DA
DESIGN OF LIGANDS SELECTIVE FOR THE DAG SUPERFAMILY$292,561
R01 · FY2000 · CA
BIOLOGICAL STUDIES OF PIPERIDINE ANALOGS OF COCAINE$278,051
R01 · FY2000 · DA